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2Synopsis
The biochemical basis for the reduced lymphokine production by neonatal T cells compared to adult T cells
remains poorly defined. Previous studies have raised the possibility that neonatal T cells could be deficient in their
ability to transmit signals via protein kinase C (PKC). We now report that while PKC-dependent activation of
the mitogen-activated protein (MAP) kinases, c-Jun N-terminal protein kinase and the extracellular signal-
regulated protein kinase (ERK )1/ERK2, was deficient in cord blood T cells compared with adult blood T cells,
marked activation of the MAP kinases in cord blood T cells was achieved via PKC-independent means.
Consistent with a deficiency in the signalling capability of PKC, cord blood T cells were selectively deficient in the
expression of PKCbI, e, q and z. Stimulation of cord blood T cells resulted in a time-dependent increase in
PKC expression, with increases detectable by 4 hours. This was accompanied by an enhancement in MAP
kinases activation via PKC-dependent means. These novel data suggest that an inadequacy in PKC-MAP kinase
signalling may be responsible, at least in part, for the phenotype of cord blood T cells.
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3Introduction
Neonatal T cells are functionally deficient in their ability to produce a number of lymphokines [1-7] and
the biochemical basis for this is not understood. While at least 40% of adult blood T cells express the CD45RO
isoform of the common leukocyte antigen, studies in cord blood T cells, a surrogate for neonatal T cells, have
shown that greater than 97% of these cells express CD45RA  [8].  Although differences in surface phenotype can
contribute to the hyporesponsiveness of cord blood T cells, it is unlikely that these differences are the only causes
for the hyporesponsiveness of cord blood T cells. Thus, adult T cells of all subsets consistently produce higher
levels of interferon g and tumour necrosis factor a  than the corresponding cord blood T cell subsets [3,4,6]. The
difference in the level of lymphokine production between cord and adult T cells was still evident when the cells
were stimulated with PMA and A23187 [6] which directly activate protein kinase C (PKC) and the Ca 2+
signalling pathway, respectively. This implies that the reduced ability of cord blood T cells to produce
lymphokines is due, in part, to deficiencies in intracellular signalling.
PKC is composed of a family of at least 11 members which are divided into classical ( a, bI, bII and g),
novel (d, e and q) and atypical ( z, i/l, m or PKD) isozymes [9]. Each isozyme can have distinct as well as
overlapping roles [9]. PKC has been reported to regulate the activities of the mitogen-activated protein (MAP)
kinases. For example, depletion of PKC inhibits the activation of the extracellular signal-regulated protein kinase
(ERK)1 and ERK2 (10), and in T cells, PKCa and PKCe have been reported to be required for the activation
of the ERK1/ERK2 modules while PKCq is required for the activation of c- jun N-terminal protein kinase (JNK)
[11,12]. The PKC-MAP kinase signalling pathways play crucial roles in regulating T cell lymphokine production.
Thus, antisense-induced repression of PKCa expression [13] and inhibition of MAP kinase activation block T
cell lymphokine production [14-19]. T cells from PKC q-deficient mice produce less interleukin 2 than cells from
wild-type animals [20] and splenic T cells from JNK-deficient mice are also compromised in  interleukin 2
production [21]. Similarly, murine T cells which express a dominant negative mutant form of the p38 MAP kinase
produce less interferon g than wild-type T cells [22].
The failure of PMA and A23187 to overcome the deficiency in lymphokine production in cord blood T
cells [6] prompted us to investigate whether cord blood T cells were deficient in their ability to signal via PKC.
We now report that stimulation of cord blood T cells with PMA evoked a lower level of ERK1/ERK2 activation
compared to adult T cells. PKC-dependent activation of JNK was also deficient. However, strong activation of
the MAP kinases was observed if the cord cells were stimulated via PKC-independent means. Our data show,
for the first time, that cord blood T cells express lower amounts of a number of PKC isozymes than adult blood T
cells. These data strongly suggest that reduced expression of a number of PKC isozymes in cord blood T cells
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4was responsible for the deficient coupling of the MAP kinases to PKC, resulting in the reduced capacity of these
cells to produce lymphokines.
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Materials
RPMI-1640 and Hanks’ Balanced Salts Solution (HBSS) were obtained from Cell Image, The Women’s and
Children’s Hospital, (Adelaide, South Australia). Foetal Calf Serum was purchased from MultiSer, Biosciences
Pty Ltd, Australia. Lymphoprep was obtained from Nycomed, Oslo. Anti-PKC isozyme antibodies (sc-8393,
212, 209, 937, 210, 214), anti-ERK2 (sc-154) and anti-JNK1 (sc-474) antibodies were purchased from Santa
Cruz Biotech., Santa Cruz, CA. The anti-ACTIVE ERK antibody was obtained from Promega Corp., Madison,
WI. Reagent Plus enhanced chemiluminescence reagent was purchased from NEN Life Science Products, Inc.
Boston.  g-32P ATP (specific activity 4000 Ci/ mmol) was obtained from Geneworks, Adelaide, South Australia.
Reagents for flow cytometry were purchased from BD- Pharmingen, San Diego, CA.
Preparation of T cells
Umbilical cord and adult blood were obtained from mothers with normal deliveries and from healthy volunteers,
respectively, according to the institution’s guidelines on human ethics. To obtain mononuclear cells, the blood was
layered on Ficoll-hypaque (density of 1.114 s.g.). T cells from this leukocyte fraction were prepared using
Lymphoprep essentially as described previously [23]. Briefly, the mononuclear leukocyte fraction was incubated
in plastic tissue culture dishes and the non-adherent lymphocyte fraction was collected and passed through two
cycles of nylon wool columns [23]. The T cells that were eluted were at least 95% pure and 99% viable.
Preparation of cell lysates
Cells were lysed by incubation in 300 ml of buffer A  (20 mM Hepes, pH7.4, 0.5% (v/v) NP40, 100 mM NaCl,
1 mM EDTA, 2 mM Na3VO4, 2 mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride, and 10 mg/ml each of
leupeptin, aprotinin, pepstatin A and benzamidine ) for 2 hours (4 oC) with constant mixing [38]. After lysis, cell
debris was sedimented (12,000 g x 30 s) and the protein content of the soluble fractions was determined by the
Lowry's protein estimation method. Samples were stored at -20 oC until assayed.
ERK1/ERK2 activation
To assay for ERK activity, equal amounts of lysate protein were precleared with protein A sepharose and ERK2
was immunoprecipitated using an anti-ERK2 antibody, followed by the addition of protein A sepharose. Kinase
activity was assayed as described using myelin basic protein as a substrate [24]. Phosphorylated substrate was
resolved by 12% SDS PAGE and the radioactivity associated with the substrate was quantitated using an Instant
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JNK assay
A solid phase assay was employed for the determination of JNK activity [24]. In preparations where an
insufficient number of cells was isolated, lysates from 2-3 experiments were pooled as appropriate, the protein
content of the resultant mixtures was obtained and the appropriate amount of protein was then loaded on to
GST-jun (1-79)-glutathione sepharose. The data obtained from these mixtures were considered as from one
experiment. Phosphorylated GST-jun (1-79) was resolved by 12% SDS PAGE and the radioactivity associated
with GST-jun (1-79) was quantitated as described above.
Western blot
To determine PKC expression, cells were sonicated in buffer containing 2% triton X-100 [10]. Equal amounts of
soluble proteins (usually 50 mg) from each pair of adult/cord blood T cell sample were subjected to Western blot
analysis. Immediately after transfer, the proteins were stained with Ponceau S (0.1% in 5% acetic acid), lightly
destained with H20, and visual checks were conducted to confirm the even loading and transfer of proteins in all
the lanes of the gels. The destaining step greatly enhanced the signal to noise ratio of the stained protein bands.
Blots that showed dissimilar protein levels between the lanes were discarded. Each blot was probed with  an
isozyme-specific anti-PKC antibody and detection was achieved by enhanced chemiluminescence [10]. The
intensity of the bands from each pair of adult-cord samples were determined by densitometric scanning (Image
Quant scanner, Molecular Dynamics, USA) and the results were expressed as % of adult band intensity. To
determine the levels of ERK1/ERK2, JNK1 and dual-phosphorylated ERK1/ERK2 in the lysates, equal amounts
of proteins (50 mg) were subjected to Western blot analysis using an anti-ERK2, anti-JNK1 and anti-ACTIVE
ERK antibody, respectively. Again, only blots which showed similar amounts of proteins between the different
lanes were used. Where appropriate, the intensity of the bands was determined by densitometric scanning.
FACS analysis
T-cells (1 x 106) were centrifuged at 600 x g for 5 min at 4°C, washed once with isoton, and resuspended in 50
ml of either antibody mix (20 ml cold isoton, 10 ml anti CD3-PC5, 10 ml anti CD45RA-FITC, 10 ml anti-
CD45RO-PE) or control antibody mix (10ml cold isoton, 40ml g1/g2a Simultest Control) for 20 min at 4°C.  The
cells were then washed twice with 2 ml cold isoton, fixed with 1% formaldehyde in isoton, and analysed on a
Becton Dickinson FACScan using Cell Quest software.
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7Statistical analysis
Where indicated, statistical analysis was performed using analysis of variance (ANOVA), Student’s unpaired T-
test or Bonferroni's multiple comparison test.
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8Results and discussion
As reported previously [1,6], cord blood T cells were found to produce less IFN g and lymphotoxin than
adult blood T cells (data not shown). Compared to adult T cells, stimulation of cord blood T cells with anti-CD3
and anti-CD28 antibodies to mimic T cell receptor and CD28 stimulation resulted in minimal JNK activation (Fig
1a). Since cord blood and adult blood T cells express similar levels of both CD3 and CD28 [3], the data in Fig
1a suggest that cord blood T cells were unable to transmit signals downstream of the T cell receptor/CD3
complex and CD28 to the JNK module. To investigate this further, T cells were incubated with PMA and
A23187 to stimulate the activity of JNK. Previous studies have demonstrated that receptor-independent
activation of JNK requires a combination of PMA and A23187 [9]. Although JNK activation was detectable in
PMA- and A23187-stimulated cord blood T cells, this was less than that observed in adult T cells (Fig 1b). The
possibility that the above results were due to a reduced amount of JNK in cord cells was considered unlikely
since similar amounts of the 46 kDa (type 1) form of JNK were found in unstimulated cord and adult T cells (Fig
1c, left panel). A minor immunoreactive band migrating with a molecular weight of approximately 48 kDa was
also apparent in the T cells, but this required a longer exposure of the film (Fig 1c, right panel). The reduced level
of MAP kinase activation was not restricted to JNK as the data in Fig 2a and 2b show that PMA also caused a
reduced level of ERK1 and ERK2 dual phosphorylation in cord blood T cells than in adult blood T cells. No
differences in the content of the ERKs were detected between unstimulated adult and cord T cells (Fig 2c).
A plausible explanation for the above results is an inadequate flow of signal from an upstream regulator
such as PKC and/or Ca2+ to the MAP kinases.  However, a deficiency in Ca 2+ signalling was excluded because
activation of ERK1 and ERK2 by PMA per se was reduced compared with adult T cells (Fig 2). We reasoned
therefore that the activities of the MAP kinases in cord cells could be increased to levels attainable in adult cells
by agents which act independently of PKC. Studies in Jurkat and other cell-types have shown that anisomycin up
regulates the activity of JNK in a PKC-independent manner [11] and pervanadate causes the activation of
ERK1/ERK2 [25]. Although  pervanadate can stimulate the ERK1/ERK2 pathway through activation of
phospholipase C g [26], such an effect in cord blood T cells is unlikely because pervanadate caused minimal
production of inositol trisphosphate in these cells [27]. Current evidence suggests that  pervanadate acts
predominantly via a compound inhibitory effect on phosphatase 2a [28] and on an uncharacterised tyrosine-
specific phosphatase [28], which could be HePTP [29]. We first confirmed that anisomycin acted independently
of PKC in cord blood T cells. Preliminary results showed that PMA- pretreatment (0.1-1 mM) for 24 hours
dose-dependently reduced PKC expression, with 1 mM reducing PKCa expression by approximately 70%.
The ability of anisomycin to stimulate JNK activity in PMA-pretreated cells was not reduced (Fig 3a) despite the
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9loss of immunoreactive PKC in these cells (data not shown). This observation is consistent with data from
previous studies that PKC depletion did not affect the ability of anisomycin to stimulate the activity of JNK in
Jurkat cells [11]. While anisomycin stimulated the activity of JNK in cord blood T cells, adult blood T cells
unexpectedly showed little or no response to anisomycin (Fig 3b). Subsequent experiments show that JNK
activity in the adult T cells could be stimulated by PMA and A23187, despite the deficient response to
anisomycin (Fig 3c). The data in Fig 4 demonstrate that  pervanadate predominantly increased ERK2
phosphorylation in cord blood T cells. While pervanadate did not increase ERK1 phosphorylation in adult T
cells, ERK2 phosphorylation was detectable but this was substantially less than that seen in cord cells (p<0.01).
These data not only demonstrate that agents which acted independently of PKC were able to elicit strong
activation of the MAP kinases in cord blood T cells but also suggest a deficiency in the coupling of PKC to the
MAP kinases in cord blood T cells.
PKC regulates the MAP kinase modules in an isozyme-specific manner in T cells. For example,
PKCa and e have been reported to regulate the ERK1/ERK2 modules while PKC q regulates the JNK module
[11,12]. To determine whether the above results could be due to a deficiency in the ability of PKC to transmit
signals downstream to the MAP kinases, triton X-100 soluble fractions were prepared from pairs of cord blood
and adult blood T cells and each sample was subjected to Western blot analysis to assess the content of PKC a,
bI, bII, e, q and z.  Each cord blood sample was found to contain less PKC bI, bII, e, q and z than adult
samples (Fig 5). Of these, the level of bI was markedly reduced. This was followed by PKC e, q and z (Fig 5).
PKCa was expressed at only slightly reduced levels compared with adult T cells. Densitometric scanning of the
blots revealed that the content of PKCa, bI, bII, e, q and z in cord blood T cells was (means + SEM) 78 + 7,
9 + 6, 48 + 10, 24 + 12, 39 + 6 and 27 + 10 %, respectively, of that found in adult blood T cells. The data in
Fig 6d show that the content of PKCd in cord blood T cells was also less than that seen in adult blood T cells.
Based on the demonstrated roles PKC e and PKCq play in MAP kinase activation in T cells [11,12], our data
provide an explanation for the low levels of MAP kinase activation in cord blood T cells. Since equal amounts of
protein were loaded for each pair of cord-adult sample, the data reflect differences in PKC :total protein ratios
between the two populations of cells.
To provide further evidence that the reduced expression of PKC isozymes was responsible for the
deficient MAP kinase activation in cord blood T cells, we investigated whether it was possible to increase the
content of PKC isozymes in cord blood T cells and whether this was accompanied by enhanced MAP kinase
activation.  It has previously been demonstrated that incubation of cord blood T cells with phytohaemagglutinin
(PHA) induced the expression of p56 lck within a few hours of treatment [30]. We found that incubation of cord
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blood T cells with PHA caused a time-dependent increase in PKC isozyme levels within the cells. The results
shown are for cells harvested at 14-16 hours after the addition of PHA (Fig 6a) but increased levels of the
isozymes were detectable at 4 hours (data not shown). However, the degree of change differed between the
isozymes (Fig 6a). All, except PKCa, exhibited at least a three-fold increase. The increase in PKC a expression
was approximately 30%. PHA over this time period did not significantly affect the total cellular protein content in
the cord cells (Fig 6b) or cell number (data not shown), suggesting a selective action of PHA on PKC levels
during this period. Furthermore, incubation of cord blood T cells in the presence of PHA for 14-16 hours did not
cause a shift in the expression of CD45RA to CD45RO (Fig 6c), implying that maturation of these cells had not
occurred during this period. When the level of PKC d in PHA-stimulated cord cells was compared with that
present in adult T cells, the data show that PHA increased PKC d in cord cells to levels found in unstimulated
adult T cells (Fig 6d).
Preincubation of cord blood T cells with PHA for 14-16 hours not only enhanced PMA and A23187-
stimulated JNK activation (Fig 7a) but also increased PMA-stimulated dual phosphorylation of the ERKs (Fig
8a, upper panel). Enhancement of PMA-stimulated ERK1/ERK2 activity was also apparent (Fig 8b). PHA-
pretreatment did not affect the expression of either the 46 kDa form of JNK (Fig 7b) or ERK2 (Fig 8a, lower
panel). These results demonstrate that increased levels of PKC expression was accompanied by enhanced
activation of MAP kinases and that these changes were not due to a change in CD45 isoform expression or an
increase in MAP kinase expression.
A deficiency in PKC expression is likely to be a significant cause of the deficient coupling between the T cell
receptor and the MAP kinases. A number of observations are consistent with this. Firstly, PKC–dependent
activation of the MAP kinases was deficient in cord blood T cells and this was not due to a difference in MAP
kinase expression between cord and adult blood T cells. Secondly, when cord blood T cells were challenged
with agents which acted independently of PKC, marked activation of the MAP kinases was achieved. Thirdly,
cord blood T cells were deficient in a number of PKC isozymes and some of these are known to regulate the
activities of ERK1/ERK2 and JNK [11,12]. Finally, increased cellular content of PKC was associated with
enhanced activation of the MAP kinases. Our data are thus consistent with a causal relationship between the low
PKC expression and inadequacy in MAP kinase activation. The deficiency in PKC expression and  MAP kinase
activation also provides an explanation for the inability of PMA and A23187 to stimulate cord blood T cells to
produce cytokines at levels seen in adult blood T cells [6]. This is consistent with the demonstration that PKC
and the ERK1/ERK2 and JNK modules are involved in regulating T cell lymphokine production [13-21]. Thus,
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our data provide evidence for an inherent signalling deficiency in cord blood T cells which is independent of
surface receptor expression.
Biochemical Journal Immediate Publication. Published on 15 Nov 2002 as manuscript BJ20021122
Copyright 2002 Biochemical Society
12
Acknowledgements
The authors thank J Ferrante for preparing the GST-jun (1-79), AJ Bilney, YQ Li, K Stacey and L Marin for
technical assistance. This work was funded by grants from the Channel 7 Children’s Research Foundation, the
Women’s and Children’s Hospital Research Foundation and the National Health and Medical Research Council
of Australia.
Biochemical Journal Immediate Publication. Published on 15 Nov 2002 as manuscript BJ20021122
Copyright 2002 Biochemical Society
13
References
1. Wilson, C.B., Lewis, D.B. (1990) Basis and implications of selectively diminished cytokine production in
neonatal susceptibility to infection. Rev. Infect. Dis. 12, Suppl 4: S410-S420
2. Chheda, S., Palkowetz, K.H., Garofalo, R., Rassin, D.K., Goldman, A.S. (1996) Decreased interleukin-10
production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor
necrosis factor-alpha and its receptors. Pediatr. Res. 40: 475-483
3. Hassan, J., Reen, D.J. (1997) Cord blood CD4+ CD45RA+ T cells achieve a lower magnitude of activation
when compared with their adult counterparts.  Immunology, 90: 397-401
4. Early, E., Reen, D.J. (1999) Rapid conversion of naive to effector T cell function counteracts diminished
primary human newborn T cell responses. Clin. Exp. Immunol. 116: 527-533
5. Takahashi, N., Imanishi, K., Nishida, H., Uchiyama, T. (1995) Evidence for immunologic immaturity of cord
blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a
superantigen. J. Immunol. 155: 5213-5219
6. Chalmers, I.M., Janossy, G., Contreras, M., Navarrete, C. (1998) Intracellular cytokine profile of cord and
adult blood lymphocytes. Blood, 92: 11-18
7. Sautois, B., Fillet, G.,  Beguin, Y. (1997) Comparative  cytokine production by in vitro stimulated
mononucleated cells from cord blood and adult blood. Exp. Hematol. 25: 103-108
8. Soares, M.V., Borthwick, N.J., Maini, M.K., Janossy, G., Salmon, M.,  Akbar, A.N. (1998) IL-7-
dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J
Immunol. 161: 5909-5917
9. Jaken, S. and Parker, P.J. (2000) Protein kinase C binding partners. BioEassys, 22: 245-254
10. Hii, C.S.T., Ferrante, A., Edwards, Y., Huang, Z.H., Hartfield, P.J., Rathjen, D.A., Poulos, A., Murray,
A.W. (1995) Activation of mitogen-activated protein kinase by arachidonic acid in rat liver epithelial WB
cells by a protein kinase C-dependent mechanism. J. Biol. Chem. 270: 4201-4204
11. Werlen, G., Jacinto, E., Xia, Y., Karin, M. (1998) Calcineurin preferentially synergizes with PKC-theta to
activate JNK and IL-2 promoter in T lymphocytes. EMBO J . 17: 3101-3111
12. Ghaffari-Tabrizi, N., Bauer, B., Villunger, A., Baier-Bitterlich, G., Altman, A., Utermann, G., Uberall, F.,
Baier, G. (1999) Protein kinase C theta, a selective upstream regulator of JNK/SAPK and IL-2 promoter
activation in Jurkat T cells. Eur. J. Immunol. 29: 132-142
13. Lopez-Lago, M.A., J. Freire-Moar, Barja, P. (1999) Inhibition of protein kinase Ca expression by antisense
RNA in transfected Jurkat cells. Eur. J. Immunol. 29: 466-476
Biochemical Journal Immediate Publication. Published on 15 Nov 2002 as manuscript BJ20021122
Copyright 2002 Biochemical Society
14
14. Cantrell, D.A. (1996) T cell antigen receptor signal transduction pathways. Cancer Surv. 27: 165-175
15. Li, Y.Q., Hii, C.S.T., Costabile, M., Goh, D., Der, C.J., Ferrante, A. (1999) Regulation of lymphotoxin
production by the p21ras-raf-MEK-ERK cascade in PHA/PMA-stimulated Jurkat cells. J. Immunol . 162:
3316-3320
16. Kasibhatla, S., Tailor, P., Bonefoy-Berard, N., Mustelin, T., Altman, A., Fotedar, A. (1999) Jun kinase
phosphorylates and regulates the DNA binding activity of an octamer binding protein, T-cell factor beta1.
Mol. Cell. Biol. 19: 2021-2031
17. Egerton, M., Fitzpatrick, D.R., Catling, A.D., Kelso, A. (1996) Differential activation of T cell cytokine
production by the extracellular signal-regulated kinase (ERK) signaling pathway. Eur. J. Immunol. 26: 2279-
2285
18. Li, Y.Q., Hii, C.S., Der,  C.J., Ferrante, A. (1999) Direct evidence that ERK regulates the
production/secretion of interleukin-2 in PHA/PMA-stimulated T lymphocytes. Immunology, 96: 524-528
19. Hoffmeyer, A., Grosse-Wilde, A., Flory, E., Neufeld, B., Kunz, M., Rapp, U.R., Ludwig S. (1999)
Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor
alpha gene expression in T lymphocytes. J. Biol. Chem . 274: 4319-4327
20. Sun, Z., Arendt, C.W., Ellmeier, W., Schaeffer, E.M., Sunshine, M.J., Gandhi, L., Annes, J., Petrzilka, D.,
Kupfer, A., Schwartzberg, P.L., Littman, D.R. (2000) PKC-theta is required for TCR-induced NF- kappaB
activation in mature but not immature T lymphocytes. Nature, 404: 402-407
21. Sabathy, K., Kallunki, T., David, J .-P., Graef, I., Karin, M., Wagner, E.F. (2001) c-Jun NH2-terminal
kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and
proliferation. J. Exp. Med. 193: 317-328
22. Rincon, M., Enslen, H., Raingeaud, J., Recht, M., Zapton, T., Su, M.S, .Penix, L.A., Davis, R.J., Flavell,
R.A. (1998) Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase
signaling pathway. EMBO J. 17: 2817-2829
23. Zhang, J.H., Ferrante, A., Arrigo, A.P., Dayer, J.M. (1992) Neutrophil stimulation and priming by direct
contact with activated human T lymphocytes. J. Immunol. 148:  177-181
24. Hii, C.S.T., Huang, Z.H., Bilney, A., Costabile, M., Murray, A.W., Rathjen, D.A., Der, C.J., Ferrante, A.
(1998) Stimulation of p38 phosphorylation and activity by  arachidonic acid in  HeLa cells, HL60
promyelocytic leukemic cells, and human neutrophils. Evidence for cell type-specific activation of mitogen-
activated protein kinases. J. Biol. Chem. 273: 19277-19282
25. Zhao, Z., Tan, Z., Diltz, C.D., You, M., Fischer, E.H. (1996) Activation of  mitogen-activated protein
Biochemical Journal Immediate Publication. Published on 15 Nov 2002 as manuscript BJ20021122
Copyright 2002 Biochemical Society
15
(MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J. Biol. Chem. 271:
22251-22255
26. Chen, J., Parsons, S., Brautigan, D.L. Tyrosine phosphorylation of protein phosphatase 2A in response to
growth stimulation and v- src transformation of fibroblasts. J. Biol. Chem. 269: 7957-7962
27. Miscia, S., Baldassarre, A.D., Sabatino, G., Bonvini, E., Rana, R.A., Vitale, M. Valerio, V.D., Manzoli,
F.A. (1999) Inefficient phospholipase C activation and reduced Lck expression characterize the signaling
defect of umbilical cord T lymphocytes. J. Immunol. 163: 2416-2424
28. Alessi, D.R., Gomez, N., Moorhead, G., Lewis, T., Keyse, S.M., Cohen, P. (1995) Inactivation of p42
MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell
lines. Curr. Biol. 5: 283-295
29. Zhou, B., Wang, Z.X., Zhao, Y., Brautigan, D.L., Zhang, Z.Y. (2002) The specificity of extracellular signal-
regulated kinase 2 dephosphorylation by protein phosphatases. J Biol Chem (In press, Jun 24,epub ahead of
print)
30. Pirenne-Ansart, H., Paillard, F., De Groote, D., Eljaafari, A., Le Gac, S., Bolt, P., Franchimont, P.,
Vaquero, C., Sterkers G. (1995) Defective cytokine expression but adult-type T-cell receptor, CD8, and
p56lck modulation in CD3- or CD2-activated T cells from neonates. Pediatr. Res. 37: 64-69
Footnotes:
The abbreviations used are: PKC, protein kinase C; ERK, extracellular signal regulated protein kinase; JNK, c-
jun N terminal kinase; MAP kinase, mitogen-activated protein kinase; PMA, phorbol 12-myristate 13- acetate ;
PHA, phytohaemagglutinin
Biochemical Journal Immediate Publication. Published on 15 Nov 2002 as manuscript BJ20021122
Copyright 2002 Biochemical Society
16
Figure legends
Figure 1  Reduced activation of JNK in cord blood T cells
Pairs of cord and adult blood T cells (2 x 10 7) were incubated in the absence (-) or presence of anti-CD3 and
anti-CD28 antibodies for 30 min (a) or with PMA (50 nM) and A23187 (0.1 mM) for up to 60 min (b). After
lysis, equal amounts of lysate protein from each sample were applied to GST-jun (1-79)-glutathione sepharose
and the activity of JNK was determined. Results are depicted as a representative autoradiogram (a, upper panel)
and pooled data (a, lower panel) from 2 experiments (mean cpm + range), or fold stimulation over kinase activity
in non-stimulated cells (means + SEM of 6 experiments) (b). In (c), equal amounts of lysate protein from four
batches of unstimulated cord (C1-C4) and adult (A1-A4) T cells were also subjected to Western blot analysis to
show that cord and adult T cells express similar amounts of the type 1 JNK (46 kDa). The right panel (c) shows
a western blot of C1 and A1 but with the film being exposed for a longer period. Significance of difference in
kinase activity between cord and adult cells: *p<0.05.
Figure 2   Reduced activation of ERK1/ERK2 in cord blood T cells
Pairs of cord and adult T cells were incubated in the presence of PMA (50 nM) or an equivalent amount of
DMSO (0.02% v/v) for 15 or 60 min. Equal amounts of lysate protein were western blotted using an anti-
ACTIVE ERK antibody. Results for six pairs of adult (A1-A6) and cord (C1-C6) samples are shown (a). Each
pair of adult and cord samples was electrophoresed on the same gel. Double arrows indicate phosphoERK1 and
phosphoERK2. A1 and C1 were stripped and reprobed with anti-ERK2 antibody (a, bottom panel). Single
arrow indicates ERK2. PhosphoERK1 and phosphoERK2 bands for all the experiments  were scanned and the
results (means + SEM) of 9 adult and 11 cord samples are expressed as fold stimulation over control (DMSO )
at 15 or 60 min (b). Data in (c) show that unstimulated cord (C1-C3) and adult (A1-A3) T cells express similar
amounts of ERKs. A1, C1 and C2 were electrophoresed on 1 gel while A2, A3 and C3 were on another.
Significance of difference in ERK phosphorylation between cord and adult cells in (b): *p<0.005
Figure 3  Anisomycin stimulated the activity of JNK in cord blood T cells in a PKC-independent
manner
(a) Cord blood T cells were preincubated with PMA (1 mM) or an equivalent amount of DMSO (0.1% v/v) for
24 hours before being stimulated with anisomycin (ANI)  (2 mg/ml in DMSO )  or DMSO (D) for 30 min. The
cells were lysed and the activity of JNK was determined. Results (autoradiogram) are representative of 3
separate experiments. In (b), pairs of cord and adult T cells were incubated with anisomycin for 30 or 60 min,
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lysed and the activity of JNK was determined. A representative autoradiogram and pooled data (means + SEM)
from 3 experiments are shown. In some experiments (c), adult blood T cells were incubated with anisomycin or
PMA and A23187 for 30 min and the activity of JNK was determined. Significance of difference in JNK activity
between the presence and absence of anisomycin in cord blood T cells (b), and between control and PMA- and
A23187-stimulated adult T cells (c): *p<0.005.
Figure 4  Pervanadate stimulated the phosphorylation of ERK2 in cord blood T cells
Pairs of cord and adult blood T cells were incubated in the presence (+) or absence (-) of pervanadate for 30
min, lysed and ERK1/ERK2 dual-phosphorylation was determined by Western blot analysis. A representative
blot is shown for phosphorylated ERK1/ERK2 (a, upper panel). The blot was stripped and reprobed with anti-
ERK2 antibody (a, lower panel). Phospho-ERK1/ERK2 bands were subjected to densitometric scanning and
the results (means + SEM) of 3 pairs of cord and adult samples are shown in (b). Significance of difference in
ERK2 phosphorylation between control and  pervanadate-stimulated cord blood T  cells, and between
pervanadate-stimulated adult and cord blood T cells: *p<0.01. Pervanadate was prepared by mixing equal
volumes of H2O2 (0.1 M) with Na3VO4 (0.1 M) and was left at room temperature for 20 min before use.
Figure 5  Reduced expression of PKC isozymes in cord blood T cells
Unstimulated T cells were sonicated in the presence of triton X-100 (2%), centrifuged and soluble fractions
containing equal amounts of protein were subjected to western blot analysis using isozyme specific anti-PKC
antibodies. Results shown are from 3-4 pairs of adult (A1-A4) and cord (C1-C4) blood T cell samples. Ponceau
Red staining of proteins on the nitrocellulose immediately after electrophoretic transfer confirmed the presence of
equal amounts of proteins between adult and cord samples within each pair of adult-cord samples.
Figure 6  PHA-pretreatment increased PKC expression without affecting total cellular protein content
and CD45 isoform expression
Cord blood T cells were incubated in the absence (-) or presence of PHA (1 mg/ml) for 14-16 hours and the
cells were sonicated and lysed or fixed. The level of PKC isozyme expression ( a and d) was determined by
Western blot analysis and protein content (b) was determined by Lowry’s method of protein determination.
Expression of CD45 isoform (c) was determined by FACS analysis after staining the cells with anti-CD3-PC5
and CD45RA-FITC or CD45RO-PE antibodies. In some experiments, the level of PKC d in PHA-stimulated
cord T cells was compared with that found in unstimulated adult T cells (d). Results shown are representative of
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at least three experiments (a, c, and d) or are the means + SEM of three experiments (b).
Figure 7  Enhancement of JNK activation in PHA-treated cord blood T cells
Cord blood T cells were preincubated in the absence or presence of PHA.  To investigate the effect of PHA-
pretreatment on JNK activation (a), PHA- preincubated cells were stimulated with PMA and A23187 for 30 min,
lysed and the activity of JNK was determined using GST jun (1-79) as a substrate. JNK activity is depicted as a
representative autoradiogram and pooled data (means + SEM) from 4 experiments. The data in (b) show that the
above treatments did not affect the level of the 46 kDa form of JNK in the cells. Significance of difference in
JNK activity between cells exposed to PMA and A23187, and those which had been pretreated with PHA and
challenged with PMA and A23187 (a): *p<0.05
Figure 8  Enhanced activation of ERK1/ERK2 in PHA-treated cord blood T cells
Cord blood T cells were preincubated in the absence or presence of PHA before being stimulated with PMA (15
min). After lysis, dual phosphorylation (a, upper panel) and activity of ERK1/ERK2 (b) were determined by
Western blot analysis and enzymatic assay using myelin basic protein (MBP) as a substrate, respectively. Equal
loading of the lanes (a, lower panel) was confirmed by stripping and reprobing the blots. A representative blot of
4 experiments is shown for ERK1/ERK2 dual phosphorylation (a) while a representative autoradiogram (b,
upper panel) and pooled data (means + SEM) of 3 experiments (b, lower panel) are shown for ERK1/ERK2
activation. Significance of difference in kinase activity between PMA stimulation per se and pretreatment with
PHA followed by PMA (b, lower panel): *p<0.01.
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